Allergy to IXIARO and BIKEN Japanese Encephalitis Vaccines

被引：4

作者：

McCallum, Andrew D. ^{[1
]}

Jones, Michael E. ^{[1
]}

机构：

[1] Western Gen Hosp, Reg Infect Dis Unit, Edinburgh EH4 2XU, Midlothian, Scotland

来源：

JOURNAL OF TRAVEL MEDICINE | 2013年 / 20卷 / 01期

关键词：

TRAVELERS; SAFETY;

D O I：

10.1111/jtm.12001

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

We describe an allergic reaction to both mouse brain-derived BIKEN and Vero cell-derived IXIARO Japanese encephalitis (JE) vaccines in a single traveler. In the absence of the stabilizers and murine proteins in the BIKEN vaccine, a common factor in both vaccines is likely to be responsible, possibly JE virus antigen itself.

引用

页码：60 / 62

页数：3

共 10 条

[1] Expert Opinion on Vaccination of Travelers Against Japanese Encephalitis [J].

Burchard, Gerd D. ;

Caumes, Eric ;

Connor, Bradley A. ;

Freedman, David O. ;

Jelinek, Tomas ;

Jong, Elaine C. ;

von Sonnenburg, Frank ;

Steffen, Robert ;

Tsai, Theodore F. ;

Wilder-Smith, Annelies ;

Zuckerman, Jane .

JOURNAL OF TRAVEL MEDICINE, 2009, 16 (03) :204-216

[2] A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines [J].

Erra, Elina O. ;

Askling, Helena Hervius ;

Rombo, Lars ;

Riutta, Jukka ;

Vene, Sirkka ;

Yoksan, Sutee ;

Lindquist, Lars ;

Pakkanen, Sari H. ;

Huhtamo, Eili ;

Vapalahti, Olli ;

Kantele, Anu .

CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) :825-834

[3]

Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1

[4]

Food and Drug Administration, PROD APPR INF PACK I

[5] Japanese Encephalitis: New Options for Active Immunization [J].

Halstead, Scott B. ;

Thomas, Stephen J. .

CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) :1155-1164

[6] A decade of vaccinating allergic travellers: A clinical audit [J].

McCallum, Andrew D. ;

Duncan, Christopher J. A. ;

MacDonald, Rona ;

Jones, Michael E. .

TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2011, 9 (05) :231-237

[7] Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO® [J].

Schuller, Elisabeth ;

Klingler, Anton ;

Dubischar-Kastner, Katrin ;

Dewasthaly, Shailesh ;

Mueller, Zsuzsanna .

VACCINE, 2011, 29 (47) :8669-8676

[8] Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine [J].

Tauber, E. ;

Kollaritsch, H. ;

von Sonnenburg, F. ;

Lademann, M. ;

Jilma, B. ;

Firbas, C. ;

Jelinek, T. ;

Beckett, C. ;

Knobloch, J. ;

McBride, W. J. H. ;

Schuller, E. ;

Kaltenboeck, A. ;

Sun, W. ;

Lyons, A. .

JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (04) :493-499

[9] Safety and immunogenicity of a Vero-cell-derived,inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial [J].

Tauber, E. ;

Kollaritsch, H. ;

Korinek, M. ;

Rendi-Wagner, P. ;

Jilma, B. ;

Firbas, C. ;

Schranz, S. ;

Jong, E. ;

Klingler, A. ;

Dewasthaly, S. ;

Klade, C. S. .

LANCET, 2007, 370 (9602) :1847-1853

[10] Japanese encephalitis: update on vaccines and vaccine recommendations [J].

Wilder-Smith, A. ;

Halstead, S. B. .

CURRENT OPINION IN INFECTIOUS DISEASES, 2010, 23 (05) :426-431

← 1 →